Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
BRIEF-Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets Aug 13 (Reuters) - Mangoceuticals Inc MGRX.O:
MANGOCEUTICALS INC.’S MERGER PARTNER, NUCLEA ENERGY, INC., ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE MOLTEX ENERGY’S ADVANCED NUCLEAR TECHNOLOGY ASSETS
MANGOCEUTICALS - PURCHASE PRICE TO BE PAID ENTIRELY IN CASH, SUBJECT TO ADJUSTMENTS FOR EXTERNAL DEBTS
Source text: ID:nGNXbbTWtV
Further company coverage: MGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM